Form4insider filings, from the source

SEC Form 4 · accession 0001645470-19-000006

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Jan 22, 2019
Accepted (ET)
Jan 29, 2019 · 4:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 22, 2019P5,000$0.0267A20,878,123D
Common StockJan 22, 2019P5,000$0.0267A20,883,123D
Common StockJan 22, 2019P10,000$0.0267A20,893,123D
Common StockJan 22, 2019P5,000$0.027A20,898,123D
Common StockJan 22, 2019P5,000$0.0259A20,903,123D
Common StockJan 22, 2019P5,000$0.0259A20,908,123D
Common StockJan 22, 2019P5,000$0.0259A20,913,123D
Common StockJan 22, 2019P10,000$0.026A20,923,123D
Common StockJan 22, 2019P500$0.0259A20,923,623D
Common StockJan 23, 2019P5,000$0.027A20,928,623D
Common StockJan 23, 2019P5,000$0.0262A20,933,623D
Common StockJan 23, 2019P5,000$0.0258A20,938,623D
Common StockJan 24, 2019P5,000$0.028A20,943,623D
Common StockJan 24, 2019P5,000$0.0279A20,948,623D
Common StockJan 25, 2019P5,000$0.0296A20,953,623D
Common StockJan 25, 2019P5,000$0.0296A20,958,623D
Common StockJan 25, 2019P5,000$0.0276A20,963,623D
Common StockJan 25, 2019P5,000$0.0289A20,968,623D
Common StockJan 25, 2019P5,000$0.029A20,973,623D
Common StockJan 25, 2019P5,000$0.029A20,978,623D
Common StockJan 25, 2019P5,000$0.0289A20,983,623D
Common StockJan 25, 2019P10,000$0.0288A20,993,623D

Table II — derivative securities

No Table II lines on this filing.